美國施壓ASML停止向中國出口光刻機 國家外交部:美方霸道霸淩行徑嚴重違背國際貿易規則
對於美國施壓荷蘭ASML(ASML.US)停止向中國出口光刻機,中國外交部發言人汪文斌表示,中方一貫反對美國泛化國家安全概念,以各種借口脅迫其他國家搞對華科技封鎖。半導體是高度全球化的產業,在各國經濟深度融合的背景下,美方有關霸道霸淩行徑嚴重違背國際貿易規則,嚴重破壞全球半導體產業格局,嚴重衝擊國際產業鏈供應鏈的安全和穩定,必將自食其果。
汪文斌續稱,中方敦促荷方秉持客觀公正立場和市場原則,尊重契約精神,以實際行動維護中荷兩國和雙方企業的共同利益,維護國際產業鏈供應鏈的穩定和自由開放、公正、非歧視的國際貿易環境。中方將密切關注有關動向,堅決維護自身合法權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.